S.No. |
Title |
Source Title |
Authors |
DOI |
Citing Works Count |
1 |
Neuroprotective Effects of Medicinal Plants in Cerebral Hypoxia and Anoxia: A Systematic Review
|
The Natural Products Journal
|
Nasibeh Amirzargar; Saeid Heidari-Soureshjani; Qian Yang; Saber Abbaszadeh; Mojtaba Khaksarian
|
10.2174/2210315509666190820103658
|
0
|
2 |
Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery.
|
Current Topics In Medicinal Chemistry
|
Ariane Sternberg; Dwight L. McKee; Cord Naujokat
|
10.2174/1568026620999200517043137
|
9
|
3 |
The Microbiome: A Reservoir to Discover New Antimicrobials Agents.
|
Current Topics In Medicinal Chemistry
|
Sébastien Boutin; Alexander H. Dalpke
|
10.2174/1568026620666200320112731
|
0
|
4 |
Carnosine and Diabetic Nephropathy
|
Current Medicinal Chemistry
|
Verena Peters; Benito A. Yard; Claus Peter Schmitt
|
10.2174/0929867326666190326111851
|
7
|
5 |
The "Big Five" Phytochemicals Targeting Cancer Stem Cells: Curcumin, EGCG, Sulforaphane, Resveratrol and Genistein
|
Current Medicinal Chemistry
|
Cord Naujokat; Dwight L. McKee
|
10.2174/0929867327666200228110738
|
7
|
6 |
The Effect of PDE5 Inhibitors on the Male Reproductive Tract.
|
Current Pharmaceutical Design
|
Nikolaos Sofikitis; A. Kaltsas; Fotios Dimitriadis; Jens Rassweiler; Nikolaos Grivas; A. Zachariou; Apostolos Kaponis; Panagiota Tsounapi; Napoleon Paterakis; Andreas Karagiannis; Sotirios Skouros; Ioannis Giannakis; Ioannis Champilomatis; Minas Paschopou
|
10.2174/1381612826666200226121510
|
3
|
7 |
Vascular Damage in Obesity and Diabetes: Highlighting Links Between Endothelial Dysfunction and Metabolic Disease in Zebrafish and Man.
|
Current Vascular Pharmacology
|
Lucas M Wiggenhauser; Jens Kroll
|
10.2174/1570161116666181031101413
|
6
|
8 |
Overview of Genomic Tools for Circular Visualization in the Next-generation Genomic Sequencing Era.
|
Current Genomics
|
Alisha Parveen; Sukant Khurana; Abhishek Kumar
|
10.2174/1389202920666190314092044
|
1
|
9 |
Modulation of ABC Transporters by Nuclear Receptors: Physiological, Pathological and Pharmacological Aspects.
|
Current Medicinal Chemistry
|
Juan Pablo Rigalli; Guillermo Nicolás Tocchetti; Johanna Weiss
|
10.2174/0929867324666170920141707
|
9
|
10 |
An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth.
|
Current Radiopharmaceuticals
|
Alfred Morgenstern; Christos Apostolidis; Clemens Kratochwil; Mike Sathekge; Leszek Królicki; Frank Bruchertseifer
|
10.2174/1874471011666180502104524
|
64
|
11 |
Protein and Peptide Studies in Kidney Disease: Prediction, Diagnosis and Treatment.
|
Protein And Peptide Letters
|
Jiaguo Huang
|
10.2174/092986652506180810154427
|
0
|
12 |
Optimization of Protein and Peptide Drugs Based on the Mechanisms of Kidney Clearance.
|
Protein And Peptide Letters
|
Huizi Wu; Jiaguo Huang
|
10.2174/0929866525666180530122835
|
7
|
13 |
AMPA Receptor Antagonist CFM-2 Decreases Survivin Expression in Cancer Cells.
|
Anti-cancer Agents In Medicinal Chemistry
|
Domingo Sanchez Ruiz; Hella Luksch; Marco Sifringer; Achim Temme; Christian Staufner; Wojciech Rzeski; Jenny Marzahn; Aneta Grabarska; Chrysanthy Ikonomidou; Andrzej Stepulak
|
10.2174/1871520618666180228123406
|
3
|
14 |
Drug-Induced Nephrotoxicity and Drug Metabolism in Renal Failure.
|
Current Drug Metabolism
|
Jiaguo Huang
|
10.2174/138920021907180709121120
|
2
|
15 |
Drug-Induced Nephrotoxicity: Pathogenic Mechanisms, Biomarkers and Prevention Strategies
|
Current Drug Metabolism
|
Huizi Wu; Jiaguo Huang
|
10.2174/1389200218666171108154419
|
13
|
16 |
Sodium-glucose Cotransporter 2 Inhibitors: Glucose Lowering Against other Hypoglycemic Agents.
|
Cardiovascular & Hematological Disorders Drug Targets
|
Konstantinos Avranas; Konstantinos Imprialos; Konstantinos Stavropoulos; Georgios Lales; Alexandos Manafis; Anastasia Skalkou; Lars P. Kihm
|
10.2174/1871529x18666180206160838
|
3
|
17 |
Sodium-glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis; from Pathophysiology to Clinical Practice.
|
Cardiovascular & Hematological Disorders Drug Targets
|
Dimitrios Patoulias; Alexandros Manafis; Christos Mitas; Konstantinos Avranas; Georgios Lales; Ioanna Zografou; Christos Sambanis; Asterios Karagiannis
|
10.2174/1871529x18666180206123149
|
10
|
18 |
Human Disease-Protein Network
|
Current Proteomics
|
Yangmei Cheng; Hao Zhang; Hui Zheng; Jun Zhang; Yang Hu; Liang Cheng
|
10.2174/1570164614666171031154904
|
0
|
19 |
Essential Oil Composition, In Vivo Antioxidant, and Antimicrobial Activities of Pimpinella pruatjan from West Java, Indonesia
|
The Natural Products Journal
|
Agustina D.R. Nurcahyanti; Issam J. Nasser; Frank Sporer; Bernhard Wetterauer; Ireng D. Kadarso; Jürgen Reichling; Michael Wink
|
10.2174/2210315507666170620093210
|
4
|
20 |
Editorial: Targeting of Cancer Cells and Tumor Microenvironment: Perspectives for Personalized Therapy.
|
Current Pharmaceutical Design
|
Julia Kzhyshkowska; Mariano Bizzarri; Ron N. Apte; Nadezhda V. Cherdyntseva
|
10.2174/138161282332171221165319
|
3
|
21 |
Multicyclic Peptides as Scaffolds for the Development of Tumor Targeting Agents
|
Current Medicinal Chemistry
|
Anastasia Loktev; Uwe Haberkorn; Walter Mier
|
10.2174/0929867324666170316120304
|
4
|
22 |
High Sensitivity Troponin I and T Reflect the Presence of Obstructive and Multi-Vessel Coronary Artery Disease Being Assessed by Coronary Computed Tomography Angiography.
|
Current Pharmaceutical Biotechnology
|
Nadine Reckord; Michael Behnes; Michele Natale; Agnibh Mukherji; Jonas Rusnak; Uzair Ansari; Siegfried Lang; Ursula Hoffmann; Martin Borggrefe; Thomas Henzler; Michael Neumaier; Maximilian Kittel; Kambis Mashayekhi; Thomas Bertsch; Ibrahim Akin
|
10.2174/1389201018666170601082145
|
5
|
23 |
Biomarkers in Cardiomyopathies and Prediction of Sudden Cardiac Death.
|
Current Pharmaceutical Biotechnology
|
M. Kruska; Ibrahim El-Battrawy; Michael Behnes; Martin Borggrefe; Ibrahim Akin
|
10.2174/1389201018666170623125842
|
6
|
24 |
Biomarkers in Stable Coronary Artery Disease.
|
Current Pharmaceutical Biotechnology
|
Jonas Rusnak; Christian Fastner; Michael Behnes; Kambis Mashayekhi; Martin Borggrefe; Ibrahim Akin
|
10.2174/1389201018666170630120805
|
7
|
25 |
The Use of Biomarkers in Sepsis: A Systematic Review.
|
Current Pharmaceutical Biotechnology
|
K. Giannakopoulos; Ursula Hoffmann; Uzair Ansari; Thomas Bertsch; Martin Borggrefe; Ibrahim Akin; Michael Behnes
|
10.2174/1389201018666170601080111
|
17
|
26 |
Contribution and Value of Biomarkers in Acute Aortic Syndromes.
|
Current Pharmaceutical Biotechnology
|
Mustafa Yildiz; Dogac Oksen; Michael Behnes; Ibrahim Akin
|
10.2174/1389201018666170615081727
|
3
|
27 |
An Expanding Role of Biomarkers in Pulmonary Arterial Hypertension.
|
Current Pharmaceutical Biotechnology
|
Mustafa Yildiz; Alparslan Sahin; Michael Behnes; Ibrahim Akin
|
10.2174/1389201018666170615082510
|
6
|
28 |
Editorial: Circulating Biomarkers in Cardiovascular Diseases - A Field of Theoretical Research or Realistic Clinical Application?
|
Current Pharmaceutical Biotechnology
|
Michael Behnes; Ibrahim Akin
|
10.2174/138920101806170815094207
|
1
|
29 |
Advantages and Limitations of Current Biomarker Research: From Experimental Research to Clinical Application.
|
Current Pharmaceutical Biotechnology
|
Seung-Hyun Kim; Christel Weiß; Ursula Hoffmann; Martin Borggrefe; Ibrahim Akin; Michael Behnes
|
10.2174/1389201018666170601091205
|
7
|
30 |
Clinically Relevant Biomarkers in Acute Heart Failure: An Update.
|
Current Pharmaceutical Biotechnology
|
Agnibh Mukherji; Uzair Ansari; Martin Borggrefe; Ibrahim Akin; Michael Behnes
|
10.2174/1389201018666170623090817
|
2
|
31 |
The Two Faces of Interleukin-17A in Atherosclerosis.
|
Current Drug Targets
|
Mohammadreza Akhavanpoor; Hamidreza Akhavanpoor; Christian A. Gleissner; Susanne Wangler; Andreas O Doesch; Hugo A. Katus; Christian Erbel
|
10.2174/1389450117666161229142155
|
7
|
32 |
Genetic Imbalance in Patients with Cervical Artery Dissection.
|
Current Genomics
|
Caspar Grond-Ginsbach; Bowang Chen; Michael Krawczak; Rastislav Pjontek; Philip Ginsbach; Yanxiang Jiang; Sherine Abboud; M. Arnold; Anna Bersano; Tobias Brandt; Valeria Caso; Stéphanie Debette; Martin Dichgans; Andreas Geschwendtner; Giacomo Giaca
|
10.2174/1389202917666160805152627
|
15
|
33 |
L-Canavanine Potentiates Cytotoxicity of Chemotherapeutic Drugs in Human Breast Cancer Cells.
|
Anti-cancer Agents In Medicinal Chemistry
|
Agustina D.R. Nurcahyanti; Michael Wink
|
10.2174/1871520616666160223111551
|
2
|
34 |
One Stage Bilateral Total Hip Arthroplasty in Siblings with Larsen Syndrome.
|
The Open Orthopaedics Journal
|
Christian Merle; Wenzel Waldstein; Joseph D. Lipman; Maximilian F. Kasparek; Friedrich Boettner
|
10.2174/1874325001610010569
|
1
|
35 |
PEGylated Peptide-Based Imaging Agents for Targeted Molecular Imaging.
|
Current Protein & Peptide Science
|
Huizi Wu; Jiaguo Huang
|
10.2174/1389203717666160101123832
|
6
|
36 |
Tumor Stroma Manipulation By MSC
|
Current Drug Targets
|
Giulia Grisendi; Carlotta Spano; Filippo Rossignoli; Naomi D’souza; Giulia Golinelli; Agnese Fiori; Edwin M. Horwitz; Valentina Guarneri; Federico Piacentini; Paolo Paolucci; Massimo Dominici
|
10.2174/1389450117666160307143226
|
8
|
37 |
A Comprehensive Review on the Genetic Regulation of Cisplatin-induced Nephrotoxicity
|
Current Genomics
|
Zeneida Herrera-Pérez; Norbert Gretz; Harsh Dweep
|
10.2174/1389202917666160202220555
|
17
|
38 |
The Early Bird Catches the Worm – Can Evolution Teach us Lessons in Fighting HIV?
|
Current HIV Research
|
Torsten Schaller; Nikolas Herold
|
10.2174/1570162x14999160224094914
|
4
|
39 |
The Use of Novel Oral Anticoagulants in Atrial Fibrillation
|
Cardiovascular & Hematological Disorders Drug Targets
|
Uzair Ansari; Michael Behnes; Christian Fastner; Ibrahim Akin
|
10.2174/1871529x1502151209111019
|
1
|
40 |
New Oral Anticoagulation after Heart Valve Replacement.
|
Cardiovascular & Hematological Disorders Drug Targets
|
Ibrahim El-Battrawy; Stefan Baumann; Aydin Huseynov; Ibrahim Akin
|
10.2174/1871529x1502151209111735
|
1
|
41 |
Novel Oral Anticoagulation Laboratory Monitoring, Interaction and Treatment of Complications.
|
Cardiovascular & Hematological Disorders Drug Targets
|
Aydin Huseynov; Stefan Baumann; Ibrahim El-Battrawy; Ibrahim Akin
|
10.2174/1871529x1502151209112437
|
0
|
42 |
New Oral Anticoagulants in Coronary Artery Disease.
|
Cardiovascular & Hematological Disorders Drug Targets
|
Michael Behnes; Christian Fastner; Uzair Ansari; Ibrahim Akin
|
10.2174/1871529x1502151209111429
|
4
|
43 |
Novel Oral Anticoagulation During Pulmonary Vein Isolation and Cardioversion.
|
Cardiovascular & Hematological Disorders Drug Targets
|
Christian Fastner; Michael Behnes; Uzair Ansari; Ibrahim Akin
|
10.2174/1871529x1502151209112128
|
0
|
44 |
Successful Combination of Sequential Gene Therapy and Rescue Allo-HSCT in Two Children with X-CGD - Importance of Timing
|
Current Gene Therapy
|
Ulrich Siler; Anna Paruzynski; Heidi Holtgreve-Grez; Elena Kuzmenko; Ulrike Koehl; E.D. Renner; Canan Alhan; Arjan A. van de Loosdrecht; Joachim Schwäble; Thomas Pfluger; Joelle Tchinda; Markus Schmugge; Anna Jauch; Sonja Naundorf; Klaus Kühlcke
|
10.2174/1566523215666150515145255
|
42
|
45 |
A Structural Feature of the Non-Peptide Ligand Interactions with Mice Mu-Opioid Receptors
|
Current Computer-aided Drug Design
|
Hamid R. Noori; Christian Mücksch; Herbert M. Urbassek
|
10.2174/1573409910666141031093504
|
4
|
46 |
Mouse models of autoimmune diseases - autoimmune myocarditis.
|
Current Pharmaceutical Design
|
Anna-Maria Müller; Andrea Fischer; Hugo A. Katus; Ziya Kaya
|
10.2174/1381612821666150316123711
|
14
|
47 |
Synergistic antimicrobial activity of combinations of sanguinarine and EDTA with vancomycin against multidrug resistant bacteria.
|
Drug Metabolism Letters
|
Razan Hamoud; Jürgen Reichling; Michael Wink
|
10.2174/187231280802150212100742
|
19
|
48 |
Rational Design of CPP-based Drug Delivery Systems: Considerations from Pharmacokinetics
|
Current Pharmaceutical Biotechnology
|
Arite Mickan; Dikran Sarko; Uwe Haberkorn; Walter Mier
|
10.2174/138920101503140822101814
|
9
|
49 |
Recent developments in drug-eluting coronary stents.
|
Cardiovascular & Hematological Disorders Drug Targets
|
Mustafa Yildiz; Banu Sahin Yildiz; Mustafa Ozan Gürsoy; Ibrahim Akin
|
10.2174/1871529x14666140823121609
|
4
|
50 |
Deciphering the Systems Biology of mTOR Inhibition by Integrative Transcriptome Analysis
|
Current Pharmaceutical Design
|
Sophie Domhan; Christian Schwager; Quanxiang Wei; Stefan Muschal; Claudia Sommerer; Christian Morath; Wolfgang Wick; Christian Maercker; Jürgen Debus; Martin Zeier; Peter E. Huber; Amir Abdollahi
|
10.2174/138161282001140113125549
|
15
|
51 |
Novel Monocyte Biomarkers of Atherogenic Conditions
|
Current Pharmaceutical Design
|
Alexei Gratchev; Ilja Ovsiy; Ioannis Manousaridis; Vladimir Riabov; Alexander N. Orekhov; Julia Kzhyshkowska
|
10.2174/1381612811319330004
|
15
|
52 |
Reactive Oxygen Species in Cancer Biology and Anticancer Therapy
|
Current Medicinal Chemistry
|
Yuhui Yang; Svetlana Karakhanova; Jens Werner; Alexandr V. Bazhin
|
10.2174/0929867311320999165
|
84
|
53 |
In-Silico Algorithms for the Screening of Possible microRNA Binding Sites and Their Interactions.
|
Current Genomics
|
Harsh Dweep; Carsten Sticht; Norbert Gretz
|
10.2174/1389202911314020005
|
52
|
54 |
Vitamin D and Cancer Mortality: Systematic Review of Prospective Epidemiological Studies
|
Anti-cancer Agents In Medicinal Chemistry
|
Stefan Pilz; Katharina Kienreich; Andreas Tomaschitz; Eberhard Ritz; Elisabeth Lerchbaum; Barbara Obermayer-Pietsch; Veronika Matzi; Joerg Lindenmann; Winfried März; Sara Gandini; Jacqueline M. Dekker
|
10.2174/187152013804487407
|
55
|
55 |
Diagnostic Tests for the Detection of Human Papillomavirus-associated Cervical Lesions
|
Current Pharmaceutical Design
|
Miriam Reuschenbach; Magnus von Knebel Doeberitz
|
10.2174/1381612811319080002; 10.2174/138161213804805612
|
9
|
56 |
Delayed cerebral ischemia after subarachnoid hemorrhage: from vascular spasm to cortical spreading depolarizations.
|
Current Neurovascular Research
|
Zelong Zheng; Renán Sánchez-Porras; Edgar Santos; Andreas Unterberg; Oliver W. Sakowitz
|
10.2174/156720212803530663
|
9
|
57 |
Anandamide dysfunction in prodromal and established psychosis.
|
Current Pharmaceutical Design
|
F. Markus Leweke
|
10.2174/138161212802884843
|
20
|
58 |
Potential protective effects of cannabidiol on neuroanatomical alterations in cannabis users and psychosis: a critical review.
|
Current Pharmaceutical Design
|
Derik Hermann; Miriam Schneider
|
10.2174/138161212802884825
|
36
|
59 |
Postnatal Neurogenesis and Dopamine Alterations in Early Psychosis
|
Recent Patents On CNS Drug Discovery
|
Dragos Inta; Juan M. Lima-Ojeda; Peter Gass; Paolo Fusar-Poli
|
10.2174/157488912803251998
|
8
|
60 |
MicroRNAs in cancer: small molecules, big chances.
|
Anti-cancer Agents In Medicinal Chemistry
|
Mohammed Abba; Giridhar Mudduluru; Heike Allgayer
|
10.2174/187152012802650273
|
28
|
61 |
Platelet-Derived Chemokines in Atherogenesis: What’s New?
|
Current Vascular Pharmacology
|
Christian A. Gleissner
|
10.2174/157016112801784521
|
17
|
62 |
Bifunctional chelators in the design and application of radiopharmaceuticals for oncological diseases.
|
Current Medicinal Chemistry
|
Dikran Sarko; Michael Eisenhut; Uwe Haberkorn; Walter Mier
|
10.2174/092986712800609751
|
26
|
63 |
Hippocampal morphology and autobiographic memory in mild cognitive impairment and Alzheimer's disease.
|
Current Alzheimer Research
|
Philipp A. Thomann; Ulrich Seidl; Julia Brinkmann; Dusan Hirjak; Tanja V. Traeger; R. Christian Wolf; Marco Essig; Johannes Schrode
|
10.2174/156720512800492558
|
21
|
64 |
Evolution of global and local grey matter atrophy on serial MRI scans during the progression from MCI to AD.
|
Current Alzheimer Research
|
Gabriela Spulber; Eini Niskanen; Stuart W. S. MacDonald; Miia Kivipelto; Daniel Ferreira Padilla; Valtteri Julkunen; Merja Hallikainen; Ritva Vanninen; Lars-Olof Wahlund; Hilkka Soininen
|
10.2174/156720512800492486
|
40
|
65 |
Microbubbles as a vehicle for gene and drug delivery: current clinical implications and future perspectives.
|
Current Pharmaceutical Design
|
Nicolas Geis; Hugo A. Katus; Raffi Bekeredjian
|
10.2174/138161212800099946
|
73
|
66 |
Why and how do microbubbles enhance the effectiveness of diagnostic and therapeutic interventions in cerebrovascular disease
|
Current Pharmaceutical Design
|
Stephen Meairs; Rolf Kern; Angelika Alonso
|
10.2174/138161212800099982
|
8
|
67 |
Immune Reconstitution During the First Year of Antiretroviral Therapy of HIV-1-Infected Adults in Rural Burkina Faso
|
The Open AIDS Journal
|
Fabrice Tiba; Frans Nauwelaers; Siaka Traoré; Boubacar Coulibaly; Thierry Ouedraogo; Adama Compaore; Hans-Georg Kräusslich; Thomas Böhler
|
10.2174/1874613601206010016
|
6
|
68 |
What can we learn from single molecule trajectories
|
Current Protein & Peptide Science
|
Verena Ruprecht; Markus Axmann; Stefan Wieser; Gerhard J. Schütz
|
10.2174/138920311798841753
|
7
|
69 |
E-health for individualized prevention of eating disorders.
|
Clinical Practice And Epidemiology In Mental Health : CP & EMH
|
Katajun Lindenberg; Markus Moessner; Joanna Harney; Orla McLaughlin; Stephanie Bauer
|
10.2174/1745017901107010074
|
28
|
70 |
Regulation of gene expression by retinoids.
|
Current Medicinal Chemistry
|
Philipp M. Amann; Stefan B. Eichmüller; Jan Schmidt; Alexandr V. Bazhin
|
10.2174/092986711795029618
|
53
|
71 |
Vaccination and antiviral treatment of neglected diseases caused by flaviviral infections.
|
Current Medicinal Chemistry
|
K. Schleich; Cindy Nürnberger; A. Sobanski; Thomas Efferth
|
10.2174/092986711794480168
|
9
|
72 |
Current treatment concepts of CML.
|
Current Cancer Drug Targets
|
Armin Leitner; Andreas Hochhaus; Martin C. Müller
|
10.2174/156800911793743637
|
17
|
73 |
Inhibition of Membrane Complement Inhibitor Expression (CD46, CD55, CD59) by siRNA Sensitizes Tumor Cells to Complement Attack In Vitro
|
Current Cancer Drug Targets
|
Nicolas Geis; Stefanie Zell; Renate Rutz; Wenhan Li; Thomas Giese; Srinivas Mamidi; Stefan Schultz; Michael Kirschfink
|
10.2174/156800910793357952
|
43
|
74 |
Acamprosate: how, where, and for whom does it work? Mechanism of action, treatment targets, and individualized therapy.
|
Current Pharmaceutical Design
|
Falk Kiefer; Karl Mann
|
10.2174/138161210791516341
|
51
|
75 |
Trypanosomatid parasites causing neglected diseases.
|
Current Medicinal Chemistry
|
Kathrin Nussbaum; J. Honek; C. M. C.v.C. Cadmus; Thomas Efferth
|
10.2174/092986710790979953
|
60
|
76 |
You Cannot Have Your Cake and Eat It, too: How Induced Goal Conflicts Affect Complex Problem Solving
|
The Open Psychology Journal
|
Christine Blech; Joachim Funke
|
10.2174/1874350101003010042
|
21
|
77 |
Subjective Outcomes Assessment in Chronic Rhinosinusitis
|
The Open Otorhinolaryngology Journal
|
Ingo Baumann
|
10.2174/1874428101004010028
|
9
|
78 |
Evaluation of Quality of Life in Patients Treated with Traditional Chinese Medicine
|
The Open Otorhinolaryngology Journal
|
Serkan Sertel; Henry Johannes Greten; Hans-Joachim Kraemer; Thomas Efferth; Peter K. Plinkert; Ingo Baumann
|
10.2174/1874428101004010062
|
8
|
79 |
Benzamides as melanotropic carriers for radioisotopes, metals, cytotoxic agents and as enzyme inhibitors.
|
Current Medicinal Chemistry
|
Doerte Oltmanns; Michael Eisenhut; Walter Mier; Uwe Haberkorn
|
10.2174/092986709788612684
|
12
|
80 |
On wage policies and unemployment
|
The Open Economics Journal
|
Andreas Irmen
|
10.2174/1874919400902010039
|
0
|
81 |
The association of connective tissue disorders with cervical artery dissections.
|
Current Molecular Medicine
|
Caspar Grond-Ginsbach; Stéphanie Debette
|
10.2174/156652409787581547
|
49
|
82 |
Hemichannels in cerebral ischemia
|
Current Molecular Medicine
|
Panagiotis Bargiotas; Hannah Monyer; Markus Schwaninger
|
10.2174/156652409787581646
|
52
|
83 |
Oxygen therapy in acute ischemic stroke - experimental efficacy and molecular mechanisms.
|
Current Molecular Medicine
|
Sven Poli; Roland Veltkamp
|
10.2174/156652409787581619
|
46
|
84 |
Targeting Histone Deacetylases in Neuroblastoma
|
Current Pharmaceutical Design
|
Olaf Witt; Hedwig E. Deubzer; M Lodrini; Till Milde; I. Oehme
|
10.2174/138161209787315774
|
52
|
85 |
Cross-clade recognition of HIV-1 CAp24 by CD4+ T cells in HIV-1-infected individuals in Burkina Faso and Germany.
|
The Open AIDS Journal
|
Thomas Böhler; Vanessa Mrosek; Kerstin Müller; Paul Schnitzler; Martin Hartmann; Thierry Ouedraogo; B. Coulibaly; Ali Sié; Vanda Bartonova; Denis M. Tebit; Hans-Georg Kräusslich
|
10.2174/1874613600903010004
|
1
|
86 |
Evolutionary advantage and molecular modes of action of multi-component mixtures used in phytomedicine.
|
Current Drug Metabolism
|
Michael Wink
|
10.2174/138920008786927794
|
209
|
87 |
Molecular mechanisms underlying St. John's wort drug interactions.
|
Current Drug Metabolism
|
Maike Kober; Kerstin Pohl; Thomas Efferth
|
10.2174/138920008786927767
|
51
|
88 |
Community Perceptions on Different Delivery Mechanisms for Insecticide- Treated Bed Nets in Rural Burkina Faso
|
The Open Public Health Journal
|
Claudia Beiersmann; Manuela De Allegri; Mamadou Sanon; Justin Tiendrebéogo; Albrecht Jahn; Olaf Mueller
|
10.2174/1874944500801010017
|
5
|
89 |
Novel Systemic Markers for Patients with Alzheimer Disease? – A Pilot Study
|
Current Alzheimer Research
|
Stefan S. Kassner; Gabriel A. Bonaterra; Elmar Kaiser; Wulf Hildebrandt; Jürgen Metz; Johannes Schröder; Ralf Kinscherf
|
10.2174/156720508785132253
|
29
|
90 |
Antibody-Targeted RNase Fusion Proteins (ImmunoRNases) for Cancer Therapy
|
Current Pharmaceutical Biotechnology
|
Jürgen Krauss; Michaela A. E. Arndt; Stefan Dübel; Susanna M. Rybak
|
10.2174/138920108784567317
|
15
|
91 |
Immunotherapy of pancreatic carcinoma.
|
Reviews On Recent Clinical Trials
|
Angela Märten
|
10.2174/157488708784223826
|
1
|
92 |
Nef and TNFα are Coplayers that Favor HIV-1 Replication in Monocytic Cells and Primary Macrophages
|
Current HIV Research
|
Georges Herbein; Audrey Varin; Anis Larbi; Carl Fortin; Ulrich Mahlknecht; Tamas Fulop; Bharat B. Aggarwal
|
10.2174/157016208783884985
|
23
|
93 |
Endoradiotherapy with peptides - Status and future development
|
Current Medicinal Chemistry
|
Uwe Haberkorn; Michael Eisenhut; Annette Altmann; Walter Mier
|
10.2174/092986708783497256
|
23
|
94 |
Gender-Specific Distribution of Hematological Parameters in Adults Living in Nouna, Burkina Faso
|
The Open Hematology Journal
|
T. Böhler; Gisela Kynast-Wolf; B. Coulibaly; A. Siè; A. Kapaun
|
10.2174/1874276900802010001
|
2
|
95 |
Frequency and severity of aggressive incidents in acute psychiatric wards in Switzerland
|
Clinical Practice And Epidemiology In Mental Health : CP & EMH
|
Christoph Abderhalden; Ian Needham; Theo Dassen; Ruud J.G. Halfens; Joachim E. Fischer; Hans-Joachim Haug
|
10.1186/1745-0179-3-30
|
64
|
96 |
Mesenchymal Stromal Cells from Umbilical Cord Blood
|
Current Stem Cell Research & Therapy
|
Karen Bieback; Harald Klüter
|
10.2174/157488807782793763
|
136
|
97 |
Alterations in Cerebral Metabolomics and Proteomic Expression during Sepsis
|
Current Neurovascular Research
|
Jochen Hinkelbein; Robert E. Feldmann; Anna Peterka; Charlotte Schubert; Dominik W. Schelshorn; Martin H. Maurer; Armin Kalenka
|
10.2174/156720207782446388
|
24
|
98 |
Cyclooxygenase-2 (COX-2) : A Therapeutic Target in Liver Cancer?
|
Current Pharmaceutical Design
|
Marco Breinig; Peter Schirmacher; Michael A. Kern
|
10.2174/138161207782360627
|
39
|
99 |
Microcirculatory Endothelial Dysfunction During Endotoxemia - Insights into Pathophysiology, Pathologic Mechanisms and Clinical Relevance
|
Current Vascular Pharmacology
|
Marcus Czabanka; Christoph Peter; Eike Martin; Andreas Walther
|
10.2174/157016107782023389
|
42
|
100 |
Onconeural Versus Paraneoplastic Antigens
|
Current Medicinal Chemistry
|
Stefan B. Eichmüller; Alexandr V. Bazhin
|
10.2174/092986707782023668
|
11
|
101 |
Standards and Novel Therapeutic Options in the Treatment of Patients with Soft Tissue Sarcoma
|
Reviews On Recent Clinical Trials
|
Bernd Kasper
|
10.2174/157488707781662706
|
14
|
102 |
Molecular Pathogenesis of Pancreatic Cancer: Advances and Challenges
|
Current Molecular Medicine
|
Thilo Welsch; Jörg Kleeff; Helmut Friess
|
10.2174/156652407781387082
|
55
|
103 |
Perspectives for gene therapy of wilson disease
|
Current Gene Therapy
|
Uta Merle; Wolfgang Stremmel; Jens Encke
|
10.2174/156652307780859053
|
13
|
104 |
Radiolabeled peptides and proteins in cancer therapy.
|
Protein And Peptide Letters
|
Carmen Wängler; Inga Buchmann; Michael Eisenhut; Uwe Haberkorn; Walter Mier
|
10.2174/092986607780090874
|
24
|
105 |
Tyrosine Kinases as Therapeutic Targets in BCR-ABL Negative Chronic Myeloproliferative Disorders
|
Current Drug Targets
|
Andreas Reiter; Christoph Walz; Nicholas C.P. Cross
|
10.2174/138945007779940124
|
29
|
106 |
Artificial organs: a new option for treating osteoarthritis.
|
Current Drug Delivery
|
J. Stove; L. Lehmann; S. Fickert; T. Aigner; R. Brenner
|
10.2174/156720107779314839
|
0
|
107 |
Protein S-100B--a prognostic marker for cerebral damage
|
Current Medicinal Chemistry
|
Mark Stroick; Marc Fatar; Andreas Ragoschke-Schumm; Klaus Fassbender; Thomas Bertsch; Michael G. Hennerici
|
10.2174/092986706778521751
|
38
|
108 |
The Cardiac hERG/IKr Potassium Channel as Pharmacological Target: Structure, Function, Regulation, and Clinical Applications
|
Current Pharmaceutical Design
|
D. Thomas; C. A. Karle; Johann Kiehn
|
10.2174/138161206777585102
|
87
|
109 |
Screening the brain: molecular fingerprints of neural stem cells.
|
Current Stem Cell Research & Therapy
|
Martin H. Maurer; Wolfgang Kuschinsky
|
10.2174/157488806775269142
|
12
|
110 |
Dose-Intensive Chemotherapy with Stem Cell Support as a Treatment Strategy for Bone and Soft-Tissue Sarcomas
|
Current Stem Cell Research & Therapy
|
Bernd Kasper; Anthony D. Ho; Gerlinde Egerer
|
10.2174/157488806775269098
|
2
|
111 |
Novel molecular targets in the treatment of cardiac hypertrophy.
|
Recent Patents On Cardiovascular Drug Discovery
|
Mark Luedde; Hugo A. Katus; Norbert Frey
|
10.2174/157489006775244290
|
31
|
112 |
Drug Delivery Across the Blood-Brain Barrier
|
Current Nanoscience
|
Anika M.S. Hartz; Björn Bauer; Carsten H. Baehr; David Miller; Gert Fricker
|
10.2174/157341305774642948
|
1
|
113 |
The renin-angiotensin system in the mammalian central nervous system.
|
Current Protein & Peptide Science
|
null von Bohlen und Halbach O
|
10.2174/1389203054546361
|
35
|
114 |
Role of nitrosative stress and poly(ADP-ribose) polymerase activation in myocardial reperfusion injury.
|
Current Vascular Pharmacology
|
Gábor Szabó; Susanne Bährle
|
10.2174/1570161054368599
|
31
|
115 |
Scintigraphic imaging of gene expression and gene transfer.
|
Current Medicinal Chemistry
|
Uwe Haberkorn; Walter Mier; Michael Eisenhut
|
10.2174/0929867053507351
|
24
|
116 |
Influence of CYP2D6 Genetics on Opioid Kinetics, Metabolism and Response
|
Current Pharmacogenomics
|
Gerd Mikus; Johanna Weiss
|
10.2174/1570160053175018
|
23
|
117 |
Non-invasive treatment of critical limb ischemia.
|
Current Drug Targets. Cardiovascular & Haematological Disorders
|
Curt Diehm; Nicolas Diehm
|
10.2174/1568006043336069
|
14
|
118 |
Monitoring therapy with gene expression profiling reveals physiological differences in drug action.
|
Current Pharmaceutical Design
|
Stefan Wölfl; A. Burchert; T. Kroll
|
10.2174/1381612043384385
|
4
|
119 |
Antiangiogenic therapy in hematologic malignancies.
|
Current Pharmaceutical Design
|
Thomas Moehler; J. Hillengass; H Goldschmidt; A D Ho
|
10.2174/1381612043452587
|
26
|
120 |
Molecular Genetic of Human Male Infertility: From Genes to New Therapeutic Perspectives
|
Current Pharmaceutical Design
|
Peter H. Vogt
|
10.2174/1381612043453261
|
84
|
121 |
Endothelin Receptor Antagonists: A New Therapeutic Option for Improving the Outcome after Solid Organ Transplantation?
|
Current Vascular Pharmacology
|
Uwe Gottmann; Fokko J. van der Woude; Claude Braun
|
10.2174/1570161033476655
|
14
|
122 |
Nitric Oxide-Mediated Endothelial Dysfunction - Is there Need to Treat?
|
Current Vascular Pharmacology
|
Tiefenbacher Cp; Kreuzer J
|
10.2174/1570161033476718
|
19
|
123 |
Potential pharmacological applications of the antithrombotic molecule high molecular weight kininogen.
|
Current Vascular Pharmacology
|
Triantafyllos Chavakis; Klaus T. Preissner
|
10.2174/1570161033386790
|
7
|
124 |
The cardiotoxicity of local anesthetics: the place of ropivacaine.
|
Current Topics In Medicinal Chemistry
|
Bernhard M. Graf
|
10.2174/1568026013395164
|
61
|
125 |
Microarrays: spotlight on gene function and pharmacogenomics.
|
Current Cancer Drug Targets
|
Matthias Nees; Craig D. Woodworth
|
10.2174/1568009013334197
|
20
|
126 |
Aldosterone- and progesterone-membrane-binding proteins: new concepts of nongenomic steroid action.
|
Current Protein & Peptide Science
|
K. Haseroth; M. Christ; E. Falkenstein; M. Wehling
|
10.2174/1389203003381270
|
10
|
127 |
Modulation of the Ceramide Level, A Novel Therapeutic Concept
|
Current Drug Targets
|
Ralf A. Claus; Stefan Russwurm; M. Meisner; Ralf Kinscherf; Hans-Peter Deigner
|
10.2174/1389450003349272
|
35
|
128 |
Polymer - Nanoparticle Assemblies for Array Based Sensing.
|
Current Organic Chemistry
|
Brian Creran; Uwe H. F. Bunz; Vincent M. Rotello
|
|
4
|
129 |
Editorial: Multiple Myeloma Immunotherapies.
|
Current Cancer Drug Targets
|
Klaus Podar
|
10.2174/156800961709171005160041
|
0
|
130 |
Modulating apoptosis: current applications and prospects for future drug development.
|
Current Medicinal Chemistry
|
Hans-Peter Deigner; Ralf Kinscherf
|
|
44
|